Rongbin Xu

Rongbin's research focuses on evaluating the health and epigenetic impacts of climate change-related environmental factors (e.g., extreme temperature, wildfires, air pollution, green space).

Since 2018, he has contributed to over 98 peer-reviewed publications (>2800 citations), including 23 papers as the first or co-first author published in Nature, NEJM, Lancet Planetary Health, JAMA Pediatrics, PloS Medicine, Environmental Health Perspective, Environment International, International Journal of Epidemiology.

His work has reached global media coverage (e.g., New York Times, CNN) and demonstrated social and policy impacts (referenced by WHO, the Parliament of Australia, etc). His research has been recognised with many competitive awards, including the prestigious Premier’s Excellence Award and Public Health Researcher Award from the Victorian government in 2024, Toxics 2021 Best PhD thesis Award and the PhD Excellence Award from Council of Academic Public Health Institutions Australasia.